WO2005091937A3 - Compositions useful for the treatment of microbial infections - Google Patents

Compositions useful for the treatment of microbial infections Download PDF

Info

Publication number
WO2005091937A3
WO2005091937A3 PCT/US2005/006761 US2005006761W WO2005091937A3 WO 2005091937 A3 WO2005091937 A3 WO 2005091937A3 US 2005006761 W US2005006761 W US 2005006761W WO 2005091937 A3 WO2005091937 A3 WO 2005091937A3
Authority
WO
WIPO (PCT)
Prior art keywords
microbial infections
compositions useful
treatment
agents
present
Prior art date
Application number
PCT/US2005/006761
Other languages
French (fr)
Other versions
WO2005091937A2 (en
Inventor
Wenyuan Shi
Li Chen
Qing-Yi Lu
David Heber
Maxwell H Anderson
Original Assignee
Univ California
C3 Scient Corp
Wenyuan Shi
Li Chen
Qing-Yi Lu
David Heber
Maxwell H Anderson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, C3 Scient Corp, Wenyuan Shi, Li Chen, Qing-Yi Lu, David Heber, Maxwell H Anderson filed Critical Univ California
Publication of WO2005091937A2 publication Critical patent/WO2005091937A2/en
Publication of WO2005091937A3 publication Critical patent/WO2005091937A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/535—Perilla (beefsteak plant)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718—Coptis (goldthread)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present invention is based on the discovery that certain chemical compounds isolated from Chinese medicinal herbs are useful as anti-microbial agents, e.g., anti­bacterial agents, anti-fungal agents, and the like. In particular, the present invention provides compositions useful for treating microbial infections such as, for example, oral microbial infections, including periodontal disease and dental caries.
PCT/US2005/006761 2004-03-04 2005-03-02 Compositions useful for the treatment of microbial infections WO2005091937A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/795,554 US7875598B2 (en) 2004-03-04 2004-03-04 Compositions useful for the treatment of microbial infections
US10/795,554 2004-03-04

Publications (2)

Publication Number Publication Date
WO2005091937A2 WO2005091937A2 (en) 2005-10-06
WO2005091937A3 true WO2005091937A3 (en) 2006-03-30

Family

ID=35056693

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/006761 WO2005091937A2 (en) 2004-03-04 2005-03-02 Compositions useful for the treatment of microbial infections

Country Status (2)

Country Link
US (1) US7875598B2 (en)
WO (1) WO2005091937A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7875598B2 (en) 2004-03-04 2011-01-25 The Regents Of The University Of California Compositions useful for the treatment of microbial infections
JP5775260B2 (en) 2006-09-06 2015-09-09 シー３ ジアン インコーポレイテッド Selectively targeted antimicrobial peptides and uses thereof
JP2010516688A (en) * 2007-01-16 2010-05-20 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Antibacterial peptide
WO2009090063A1 (en) * 2008-01-16 2009-07-23 Jado Technologies Gmbh Steroid sapogenin, androstane and triterpenoid sapogenin derivatives for the treatment and prevention of infectious diseases
US20110098495A1 (en) * 2009-10-27 2011-04-28 Chifu Huang Compositions and methods of omega polyunsaturated fatty acids for the treatment of oral diseases
KR101751486B1 (en) * 2016-03-02 2017-06-28 광주과학기술원 Composition for Enhancing BKCa Channel
EP4216920A1 (en) * 2020-09-28 2023-08-02 The Procter & Gamble Company Oral care compositions comprising prenylated flavonoids
CN112175884B (en) * 2020-10-29 2022-04-15 北京农学院 Lactobacillus plantarum SD26 and product and application thereof
CN116440149A (en) * 2022-03-15 2023-07-18 中国科学院昆明植物研究所 Application of rhizoma paridis saponin in preparing dermatophyte resisting product

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000198724A (en) * 1998-01-28 2000-07-18 Pola Chem Ind Inc Skin-beautifying preparation for external use for skin
US6346267B1 (en) * 2000-07-07 2002-02-12 Wakunaga Of America Co., Ltd. Composition and method for treatment of symptoms associated with insufficient estrogen production
US20020102316A1 (en) * 2000-12-01 2002-08-01 Weissman Glenn H. Composition and method for treating snoring
CN1415301A (en) * 2002-11-12 2003-05-07 蔡海德 Compound recipe formula containing kurarinone prostaglandin E1 and aspirin, its preparation method and application
US20030211185A1 (en) * 2001-12-12 2003-11-13 ALEXIS Brian Natural, anti-bacterial, anti-virus, anti-herpes cream
WO2004028519A1 (en) * 2002-09-26 2004-04-08 Mandom Corporation Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5221571B2 (en) * 1972-12-18 1977-06-11
US4324782A (en) 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
US4150116A (en) 1978-02-21 1979-04-17 Forsyth Dental Infirmary For Children Immunization against dental caries with glucosyltransferase antigens
ZA794413B (en) 1978-09-01 1980-08-27 Us Government Protection against dental caries
US4250262A (en) 1979-12-14 1981-02-10 Forsyth Dental Infirmary For Children Method of preparing a purified glucosyltransferase
EP0068660B1 (en) 1981-06-19 1985-04-17 Secretary of State for Social Services in Her Britannic Majesty's Gov. of the U.K. of Great Britain and Northern Ireland Protection against dental caries
US4671958A (en) 1982-03-09 1987-06-09 Cytogen Corporation Antibody conjugates for the delivery of compounds to target sites
JPS6028937A (en) 1983-07-25 1985-02-14 Kitasato Inst:The Noncariogenic antibody and composition
US4693888A (en) 1983-08-11 1987-09-15 Lion Corporation Caries-preventive composition
JPS6038329A (en) 1983-08-11 1985-02-27 Lion Corp Preventive for dental caries
JPH0641424B2 (en) 1984-11-06 1994-06-01 ライオン株式会社 Caries preventive agent
US5057313A (en) 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
US5352446A (en) 1986-03-25 1994-10-04 Council Of Governors Of The United Medical And Dental Schools Of Guy's And St. Thomas's Hospitals Method of treating dental caries with monoclonal antibodies against the antigen I and antigen I/II of streptococcus mutans
US5518721A (en) 1987-02-27 1996-05-21 Council Of Governors Of The United Medical And Dental Schools Of Guy's And St. Thomas Hospital Antibodies against Streptococcus
US5281524A (en) 1988-01-22 1994-01-25 Kanebo, Ltd. Cell-associated glucosyltransferase from Streptococcus mutans serotype, c, e or f
JP2641228B2 (en) 1988-01-22 1997-08-13 鐘紡株式会社 Antibody, caries preventive agent containing the same as an active ingredient, and methods for producing the same
US5851527A (en) 1988-04-18 1998-12-22 Immunomedics, Inc. Method for antibody targeting of therapeutic agents
JPH02177899A (en) 1988-12-28 1990-07-10 Nagase Sangyo Kk Igd monoclonal antibody specifically reactive with streptococcus mutans
NO902352L (en) 1989-05-29 1990-11-30 Lion Corp PROCEDURE FOR THE PREPARATION OF A VACCINE AGAINST DENTAL KARIES, AND VACCINE MIXTURES FOR USE AS NOSE KILLS
US5332567A (en) 1989-08-24 1994-07-26 Immunomedics Detection and treatment of infections with immunoconjugates
US5314995A (en) 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
US6197299B1 (en) 1990-07-20 2001-03-06 Pharmacia & Upjohn Ab Antibody conjugates
US5981726A (en) 1990-10-12 1999-11-09 The United States Of America As Represented By The Department Of Health And Human Services Chimeric and mutationally stabilized tumor-specific B1, B3 and B5 antibody fragments; immunotoxic fusion proteins; and uses thereof
DE69233254T2 (en) 1991-06-14 2004-09-16 Genentech, Inc., South San Francisco Humanized Heregulin antibody
US5646119A (en) 1991-11-01 1997-07-08 Periodontix, Inc. D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents
JPH05227916A (en) 1992-01-11 1993-09-07 Kanebo Ltd Dental caries preventing food
ES2102007T3 (en) 1992-01-23 1997-07-16 Merck Patent Gmbh MONOMER AND DIMER ANTIBODY FRAGMENT FUSION PROTEINS.
EP1266662A3 (en) 1992-05-01 2003-05-28 Forsyth Dental Infirmary For Children Synthetic peptide vaccines for dental caries
US5726293A (en) 1992-10-02 1998-03-10 The General Hospital Corporation Affinity purification methods involving imidazole elution
JPH06122633A (en) 1992-10-09 1994-05-06 Lion Corp Antibody having immunoactivity on streptococcus mutans and dental caries preventive
DE69232604T2 (en) 1992-11-04 2002-11-07 City Of Hope Duarte ANTIBODY CONSTRUCTS
DE69528445D1 (en) 1994-12-12 2002-11-07 Unilever Nv Anti-microbial agent
US6046037A (en) 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use
DE69711044T2 (en) 1996-04-16 2002-11-07 Novozymes As DEVICE FOR REMOVING THE DENTAL PLAQUE
US5891422A (en) 1996-10-10 1999-04-06 Warner-Lambert Company Antimicrobial composition containing a C3 -C6 alcohol
US6183744B1 (en) 1997-03-24 2001-02-06 Immunomedics, Inc. Immunotherapy of B-cell malignancies using anti-CD22 antibodies
US6455031B1 (en) 1997-06-18 2002-09-24 David G Davies Methods and compositions for controlling biofilm development
US5875798A (en) 1997-09-23 1999-03-02 Advanced Medical Instruments, Inc. Therapeutic toothpick for treating oral and systemic diseases
US5874068A (en) 1997-12-08 1999-02-23 Warner-Lambert Company Stabilized antiplaque and antigingivitis oral compositions containing N.sup.α -alkyl-L-arginine alkyl ester salts
US6303575B1 (en) 1998-05-12 2001-10-16 The Regents Of The University Of California Indolicidin analogs and methods of using same
US6673900B2 (en) 1999-11-04 2004-01-06 University College London Polypeptide hormone-phosphatonin
JP4731687B2 (en) 1998-08-21 2011-07-27 ザ リージェンツ オブ ザ ユニヴァーシティ オブ カリフォルニア Monoclonal antibodies specific for Streptococcus mutans and uses thereof
US6231857B1 (en) 1998-09-28 2001-05-15 The Regents Of The University Of California Antibodies to S. mutans and uses thereof
US20040052814A1 (en) 1998-09-28 2004-03-18 Wenyuan Shi Fusion proteins for targeted delivery of antimicrobial peptides
US6309835B1 (en) 1999-05-27 2001-10-30 Koninkiijke Philips Electronics N.V. Methods for quantitating the efficacy of oral care products
US7569542B2 (en) 1999-08-20 2009-08-04 The Regents Of The University Of California Anti-microbial targeting chimeric pharmaceutical
US20020068066A1 (en) 1999-08-20 2002-06-06 Wenyuan Shi Method for the treatment and prevention of dental caries
US20030143234A1 (en) 1999-08-20 2003-07-31 Wenyuan Shi Anti-microbial targeting chimeric pharmaceutical
JP2003532698A (en) 2000-05-10 2003-11-05 プリンストン ユニバーシティ Compounds and methods for regulating bacterial growth and pathogenesis
US6492328B2 (en) 2000-06-28 2002-12-10 The University Of Iowa Research Foundation Novispirins: antimicrobial peptides
WO2002015931A1 (en) 2000-08-24 2002-02-28 Washington Dental Service Immunologic method for the prevention of dental caries
US7754676B2 (en) 2000-09-15 2010-07-13 The United States Of America As Represented By The Department Of Health And Human Services Defensin-antigen fusion proteins
AUPR575401A0 (en) 2001-06-18 2001-07-12 Unisearch Limited Method of causing sloughing
IL145767A (en) * 2001-10-04 2006-10-31 Israel State Microbicidal formulation comprising an essential oil or its derivatives
US20040023254A1 (en) 2002-01-08 2004-02-05 Fuhrmann Jeffry J. Method to assess quorum sensing potential of microbial communities
AU2003220161A1 (en) 2002-03-12 2003-09-29 Nitto Denko Corporation Vector for transfection of eukaryotic cells
US7491691B2 (en) 2002-05-03 2009-02-17 Sindrey Dennis R Connective tissue stimulating peptides
US20030228379A1 (en) * 2002-05-28 2003-12-11 Wenyuan Shi Herbs and herbal combinations useful for the treatment of microbial infections
US7427408B2 (en) 2002-06-06 2008-09-23 The Regents Of The University Of California Quorum sensing and biofilm formation
US7875598B2 (en) 2004-03-04 2011-01-25 The Regents Of The University Of California Compositions useful for the treatment of microbial infections

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000198724A (en) * 1998-01-28 2000-07-18 Pola Chem Ind Inc Skin-beautifying preparation for external use for skin
US6346267B1 (en) * 2000-07-07 2002-02-12 Wakunaga Of America Co., Ltd. Composition and method for treatment of symptoms associated with insufficient estrogen production
US20020102316A1 (en) * 2000-12-01 2002-08-01 Weissman Glenn H. Composition and method for treating snoring
US20030211185A1 (en) * 2001-12-12 2003-11-13 ALEXIS Brian Natural, anti-bacterial, anti-virus, anti-herpes cream
WO2004028519A1 (en) * 2002-09-26 2004-04-08 Mandom Corporation Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
CN1415301A (en) * 2002-11-12 2003-05-07 蔡海德 Compound recipe formula containing kurarinone prostaglandin E1 and aspirin, its preparation method and application

Also Published As

Publication number Publication date
US7875598B2 (en) 2011-01-25
US20060135498A1 (en) 2006-06-22
WO2005091937A2 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
WO2003099110A3 (en) Herbs and herbal combinations useful for the treatment of microbial infections
WO2005091937A3 (en) Compositions useful for the treatment of microbial infections
WO2004062625A3 (en) Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease
WO2005032471A3 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
WO2006086562A3 (en) Phenylazetidinone derivatives
MY143795A (en) Tetrahydropyridoindole derivatives
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
WO2005102392A3 (en) Combinations for treating hiv infection
WO2005004802A3 (en) N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005018545A3 (en) Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005004803A3 (en) Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
NO20053855L (en) 1-Phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases.
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
WO2004006858A3 (en) Compounds, compositions, and methods employing same
WO2005051914A8 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
EP2192901A4 (en) Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
WO2006034001A3 (en) Methods of treating hiv infection
PL1638938T3 (en) Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
PL1654253T3 (en) Substituted 3-pyrrolidin-indole derivatives
DE60122015D1 (en) TREATMENT OF AFFECTIVE DISORDERS BY COMBINED EFFECT OF A NICOTINE RECEPTOR AGONIST AND A MONOAMINERGIC SUBSTANCE
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
WO2007030708A3 (en) Antimicrobial adzymes and uses thereof
NO20074167L (en) Peptidic Compounds
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase